(19)

(11)

EP 4 479 024 A1

(12)

(43) Date of publication: 25.12.2024 Bulletin 2024/52 (21) Application number: 23707495.0 (22) Date of filing: 15.02.2023

(51) International Patent Classification (IPC):  A61K 9/00(2006.01) A61P 9/08(2006.01) A61K 47/20(2006.01) A61K 31/00(2006.01) A61K 47/10(2017.01) A61P 35/00(2006.01) (52) Cooperative Patent Classification (CPC): A61K 9/0019; A61K 47/20; A61K 47/10; A61K 9/08; A61P 35/00; A61K 31/675 (86) International application number: PCT/IB2023/051366 (87) International publication number: WO 2023/156911 (24.08.2023 Gazette 2023/34)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 16.02.2022 US 202263310638 P (71) Applicant: Shorla Pharma Ltd Clonmel Co. Tipperary, E91 V329 (IE)	(72) Inventors: CUNNINGHAM, Sharon Clonmel Co. Tipperary, E91 V329 (IE) RYAN, Orlaith Clonmel Co. Tipperary, E91 V329 (IE) PLATTEEUW, Johannes Jan 5283 JH Boxtel (NL) (74) Representative: Haseltine Lake Kempner LLP  One Portwall Square Portwall Lane Bristol BS1 6BH Bristol BS1 6BH (GB)